Fina Biosolutions helps emerging market vaccine
manufacturers learn how to make affordable conjugate
vaccines and offers a variety of bioconjugation and
protein services. We are located in the heart of
Maryland’s biotech corridor.

Functionalized Dextrans

Products & Services

Fina BioPolymers has applied its expertise in polysaccharide conjugation to the production and characterization of functionalized dextrans and related products.

Fina Biosolutions, LLC mission is to help manufacture affordable conjugate vaccines for emerging markets. We are a global provider of conjugate vaccine laboratory and consulting services for the Biotech and Vaccine industry, with core expertise in conjugation chemistry, bioconjugation and conjugate vaccines.

WHITE PAPER

POSTER

POSTER

Fina Biosolutions, LLC was founded in 2006 by Dr. Andrew Lees with an initial focus on helping emerging market vaccine manufacturers learn to make affordable conjugate vaccines. FinaBio has since grown to offer a variety of bioconjugation and protein services. The company is located in the heart of Maryland’s biotechnology corridor.